Wealthfront Advisers LLC Boston Scientific Corp Transaction History

Wealthfront Advisers LLC

$32.2 Billion
Q3 2024

A detailed history of Wealthfront Advisers LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Wealthfront Advisers LLC holds 106,780 shares of BSX stock, worth $10.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

106,780

Previous 103,748 2.92%

Holding current value

$10.5 Million

Previous $7.99 Million 12.0%

% of portfolio

0.03%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$72.96 - $84.0 $221,214 - $254,688	3,032 Added 2.92%	106,780 $8.95 Million
Q2 2024 Aug 14, 2024	BUY	$67.33 - $77.71 $297,935 - $343,866	4,425 Added 4.46%	103,748 $7.99 Million
Q1 2024 Apr 19, 2024	BUY	$57.6 - $68.62 $145,152 - $172,922	2,520 Added 2.6%	99,323 $6.8 Million
Q4 2023 Feb 09, 2024	BUY	$48.64 - $57.81 $385,082 - $457,681	7,917 Added 8.91%	96,803 $5.6 Million
Q3 2023 Nov 01, 2023	BUY	$50.19 - $54.68 $295,468 - $321,901	5,887 Added 7.09%	88,886 $4.69 Million
Q2 2023 Aug 07, 2023	BUY	$49.72 - $54.64 $878,005 - $964,887	17,659 Added 27.03%	82,999 $4.49 Million
Q1 2023 Apr 28, 2023	BUY	$45.09 - $50.03 $357,112 - $396,237	7,920 Added 13.79%	65,340 $3.27 Million
Q4 2022 Feb 10, 2023	SELL	$39.56 - $47.22 $172,916 - $206,398	-4,371 Reduced 7.07%	57,420 $2.66 Million
Q3 2022 Nov 14, 2022	BUY	$36.71 - $109.66 $881,113 - $2.63 Million	24,002 Added 63.52%	61,791 $2.39 Million
Q2 2022 Jul 20, 2022	SELL	$35.24 - $47.1 $32,737 - $43,755	-929 Reduced 2.4%	37,789 $1.41 Million
Q1 2022 May 16, 2022	BUY	$40.9 - $45.1 $135,256 - $149,145	3,307 Added 9.34%	38,718 $1.71 Million
Q4 2021 Jan 21, 2022	SELL	$38.07 - $44.87 $5,482 - $6,461	-144 Reduced 0.41%	35,411 $1.5 Million
Q3 2021 Nov 15, 2021	BUY	$41.23 - $45.88 $184,545 - $205,358	4,476 Added 14.4%	35,555 $1.54 Million
Q2 2021 Aug 16, 2021	BUY	$38.58 - $44.24 $141,202 - $161,918	3,660 Added 13.35%	31,079 $1.33 Million
Q1 2021 May 14, 2021	BUY	$35.27 - $39.67 $208,657 - $234,687	5,916 Added 27.51%	27,419 $1.06 Million
Q4 2020 Feb 16, 2021	SELL	$33.15 - $41.97 $30,464 - $38,570	-919 Reduced 4.1%	21,503 $773,000
Q3 2020 Nov 16, 2020	BUY	$34.44 - $42.23 $36,781 - $45,101	1,068 Added 5.0%	22,422 $857,000
Q2 2020 Aug 14, 2020	SELL	$30.19 - $39.11 $18,868 - $24,443	-625 Reduced 2.84%	21,354 $750,000
Q1 2020 May 15, 2020	SELL	$25.83 - $45.71 $544,677 - $963,886	-21,087 Reduced 48.96%	21,979 $717,000
Q4 2019 Jan 21, 2020	SELL	$37.87 - $45.37 $33,439 - $40,061	-883 Reduced 2.01%	43,066 $1.95 Million
Q3 2019 Oct 15, 2019	SELL	$40.31 - $43.45 $22,815 - $24,592	-566 Reduced 1.27%	43,949 $1.79 Million
Q2 2019 Aug 13, 2019	SELL	$34.91 - $42.98 $119,252 - $146,819	-3,416 Reduced 7.13%	44,515 $1.91 Million
Q1 2019 May 13, 2019	BUY	$32.91 - $40.75 $12,472 - $15,444	379 Added 0.8%	47,931 $1.84 Million
Q4 2018 Feb 14, 2019	BUY	$31.73 - $39.04 $1.51 Million - $1.86 Million	47,552 New	47,552 $1.68 Million

Others Institutions Holding BSX

# of Institutions

1,558

Shares Held

1.18B

Call Options Held

6.78M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $141B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthfront Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthfront Advisers LLC with notifications on news.

Account

Wealthfront Advisers LLC Boston Scientific Corp Transaction History